We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
(-4.8%)
Cap. Flow
+$505M
Cap. Flow
% of AUM
0.65%
Top 10 Holdings %
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$83.5M |
| 2 |
S&P Global
SPGI
|
+$73.5M |
| 3 |
Tesla
TSLA
|
+$55.8M |
| 4 |
Microsoft
MSFT
|
+$45.9M |
| 5 |
Amazon
AMZN
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$88.8M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$74.7M |
| 3 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$31.7M |
| 4 |
Abbott
ABT
|
+$25.5M |
| 5 |
Exelon
EXC
|
+$23.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.74% |
| 2 | Financials | 13.53% |
| 3 | Healthcare | 13.01% |
| 4 | Consumer Discretionary | 11.66% |
| 5 | Industrials | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Syndax Pharmaceuticals
SNDX
$1.82B
| $1.01M | ﹤0.01% |
58,239
+1,516
| +3% | +$25.5K |
|
2127
Blink Charging
BLNK
$86M
| $1.01M | ﹤0.01% |
38,169
+252
| +0.7% | +$5.93K |
|
2128
Allegro MicroSystems
ALGM
$7.91B
| $1.01M | ﹤0.01% |
35,534
-3,892
| -10% | -$111K |
|
2129
C3.ai
AI
$1.62B
| $1M | ﹤0.01% |
44,231
-5,904
| -12% | -$142K |
|
2130
Genco Shipping & Trading
GNK
$1.09B
| $1M | ﹤0.01% |
42,494
-2,697
| -6% | -$49.9K |
|
|
MODN
2131
DELISTED
MODEL N, INC.
MODN
| $998K | ﹤0.01% |
37,089
+508
| +1% | +$13.3K |
|
2132
Gorman-Rupp
GRC
$2.16B
| $997K | ﹤0.01% |
27,775
-2,265
| -8% | -$87.8K |
|
|
XENT
2133
DELISTED
Intersect ENT, Inc
XENT
| $993K | ﹤0.01% |
35,439
+3,647
| +11% | +$99.9K |
|
|
AMRS
2134
DELISTED
Amyris Inc.
AMRS
| $992K | ﹤0.01% |
227,499
-9,220
| -4% | -$41.4K |
|
2135
American Well
AMWL
$231M
| $988K | ﹤0.01% |
11,729
-931
| -7% | -$78.6K |
|
2136
C4 Therapeutics
CCCC
$400M
| $987K | ﹤0.01% |
40,699
+2,423
| +6% | +$58.8K |
|
2137
Privia Health
PRVA
$2.86B
| $986K | ﹤0.01% |
36,873
+20,464
| +125% | +$483K |
|
2138
Castle Biosciences
CSTL
$988M
| $984K | ﹤0.01% |
21,936
+1,038
| +5% | +$42.9K |
|
2139
Lemonade
LMND
$4.08B
| $984K | ﹤0.01% |
37,301
-2,124
| -5% | -$60.1K |
|
|
OLPX
2140
DELISTED
Olaplex Holdings
OLPX
| $982K | ﹤0.01% |
62,830
+1,456
| +2% | +$27.8K |
|
|
RETA
2141
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $982K | ﹤0.01% |
29,981
-65
| -0.2% | -$1.93K |
|
2142
Cerus
CERS
$508M
| $972K | ﹤0.01% |
177,060
-19,263
| -10% | -$107K |
|
2143
Motorcar Parts of America
MPAA
$235M
| $971K | ﹤0.01% |
54,477
+436
| +0.8% | +$7.36K |
|
2144
Quanterix
QTRX
$114M
| $969K | ﹤0.01% |
33,203
+836
| +3% | +$25.5K |
|
2145
Orion
OEC
$389M
| $965K | ﹤0.01% |
60,404
-117
| -0.2% | -$2.02K |
|
2146
Sterling Infrastructure
STRL
$16.2B
| $965K | ﹤0.01% |
36,011
-2,539
| -7% | -$71K |
|
|
COWN
2147
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $965K | ﹤0.01% |
35,623
-2,733
| -7% | -$83.2K |
|
2148
Core & Main
CNM
$8.67B
| $957K | ﹤0.01% |
39,579
+9,663
| +32% | +$227K |
|
2149
Seneca Foods Class A
SENEA
$1.22B
| $955K | ﹤0.01% |
18,526
-907
| -5% | -$44.4K |
|
2150
Aclaris Therapeutics
ACRS
$867M
| $952K | ﹤0.01% |
55,194
+8,469
| +18% | +$116K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2022 Portfolio in Review
As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
- RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
- RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
- RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
- RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
- RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.